07:00 , Jun 16, 2014 |  BC Week In Review  |  Company News

Abzena, Alpha Cancer deal

Abzena's PolyTherics Ltd. subsidiary partnered with Alpha Cancer to develop drug conjugates to treat cancer. PolyTherics will use its ThioBridge linker technology to attach an undisclosed cytotoxic drug to Alpha Cancer's recombinant human ...
08:00 , Feb 24, 2014 |  BC Week In Review  |  Company News

Alpha Cancer, Bradmer deal

The companies signed a letter of intent to combine businesses through a reverse merger with the newco to be named Alpha Cancer Technologies Inc. The close is subject to Alpha Cancer completing a private placement...